DMC Group, LLC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.

Quarter-by-quarter ownership
DMC Group, LLC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$399,662
+8.9%
3,297
+2.9%
0.37%
+1.9%
Q2 2023$366,922
-17.5%
3,204
-50.4%
0.37%
-18.1%
Q1 2023$444,593
+111326.8%
6,458
+102.1%
0.45%
-0.4%
Q4 2022$399
-99.9%
3,195
+6.3%
0.45%
+12.8%
Q3 2022$330,000
+57.9%
3,006
+9.0%
0.40%
+61.5%
Q2 2022$209,000
+3.5%
2,757
+4.2%
0.25%
+9.3%
Q1 2022$202,0002,6450.23%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Ikarian Capital, LLC 399,400$35,962,0005.36%
Avoro Capital Advisors LLC 3,125,000$281,406,0004.79%
Varenne Capital Partners 324,661$29,236,0004.34%
Evolutionary Tree Capital Management, LLC 96,695$8,707,0004.18%
Ally Bridge Group (NY) LLC 120,000$10,806,0003.78%
Casdin Capital, LLC 1,350,000$121,568,0003.43%
Ghost Tree Capital, LLC 100,000$9,005,0003.23%
GREAT POINT PARTNERS LLC 145,405$13,094,0002.91%
Camber Capital Management LP 825,000$74,291,0002.55%
Alpha DNA Investment Management LLC 17,522$1,577,0001.00%
View complete list of SAREPTA THERAPEUTICS INC shareholders